CoChat

Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To analyze prospectively the hypothalamic-pituitary-adrenal (HPA) axis and clinical outcome in patients treated with prednisone for exacerbated chronic obstructive pulmonary disease (COPD). DESIGN: Prospective observational study. SUBJECTS AND METHODS: Patients presenting to the emergency department were randomized to receive 40 mg prednisone daily for 5 or 14 days in a placebo-controlled manner. The HPA axis was longitudinally assessed with the 1 μg corticotropin test and a clinical hypocortisolism score at baseline, on day 6 before blinded treatment, at hospital discharge, and for up to 180 days of follow-up. Prednisone was stopped abruptly, irrespective of the test results. Patients discharged with pathological test results received instructions about emergency hydrocortisone treatment. RESULTS: A total of 311 patients were included in the analysis. Mean basal and stimulated serum total cortisol levels were highest on admission (496±398 and 816±413 nmol/l respectively) and lowest on day 6 (235±174 and 453±178 nmol/l respectively). Pathological stimulation tests were found in 63, 38, 9, 3, and 2% of patients on day 6, at discharge, and on days 30, 90, and 180 respectively, without significant difference between treatment groups. Clinical indicators of hypocortisolism did not correlate with stimulation test results, but cortisol levels were inversely associated with re-exacerbation risk. There were no hospitalizations or deaths as a result of adrenal crisis. CONCLUSION: Dynamic changes in the HPA axis occur during and after the treatment of acute exacerbations of COPD. In hypocortisolemic patients who were provided with instructions about stress prophylaxis, the abrupt termination of prednisone appeared safe.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-15-0182

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 3

  1. Mayenknecht, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 1558, 10.1210/jc.83.5.1558 · doi:10.1210/jc.83.5.1558 · Paper page
  2. Schuetz, 2010, Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 140, w13109
  3. Kountz, 1997, American family physician, 55, 521

Cited by

See all 35

Metadata

Authors
Schuetz, P., Leuppi, J. D., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., Miedinger, D., Mueller, B., Scherr, A., Schindler, C., Stoeckli, R., Viatte, S., von Garnier, C., Tamm, M., & Rutishauser, J.
Affiliations
  • University Hospital of Basel (CH)
  • Swiss Tropical and Public Health Institute (CH)
  • University of Basel (CH)
Corresponding author
Rutishauser, Jonas
Venue
European Journal of Endocrinology
Published
2015-07
Volume
173
Issue
1
Pages
19-27
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2122328984
Cited by
35
References
25
Citations by year
2026: 2 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 1 · 2016: 2 · 2015: 2
FWCI
3.19
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
COPD exacerbations, hypothalamic-pituitary-adrenal axis, prednisone, glucocorticoid withdrawal, adrenal insufficiency, serum cortisol, adrenal crisis, cortisol, REDUCE trial
MeSH terms
Adrenal Cortex Function Tests, Adrenal Cortex Hormones, Adrenal Insufficiency, Adrenal Glands, Adrenocorticotropic Hormone, Aged, Female, Follow-Up Studies, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Prednisone, Prospective Studies, Treatment Outcome, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. https://app.cochat.ai/papers/10.1530/eje-15-0182
The paper
Schuetz, P., Leuppi, J. D., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., Miedinger, D., Mueller, B., Scherr, A., Schindler, C., Stoeckli, R., Viatte, S., von Garnier, C., Tamm, M., & Rutishauser, J. (2015). Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. European Journal of Endocrinology. https://doi.org/10.1530/eje-15-0182

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.